| Literature DB >> 28674658 |
Jones K Ofori1,2, Helena A Malm1,2, Ines G Mollet3, Lena Eliasson1,2, Jonathan Lou S Esguerra1,2.
Abstract
MicroRNAs are small non-coding RNAs, which negatively regulate the expression of target genes. They have emerged as important modulators in beta cell compensation upon increased metabolic demand, failure of which leads to reduced insulin secretion and type 2 diabetes. To elucidate the function of miRNAs in beta cells, insulin-secreting cell lines, such as the rat insulinoma INS-1 832/13 and the human EndoC-βH1, are widely used. Previous studies in the cancer field have suggested that miRNA expression is influenced by confluency of adherent cells. We therefore aimed to investigate whether one of the most enriched miRNAs in the pancreatic endocrine cells, miR-375, and two of its validated targets in mouse, Cav1 and Aifm1, were differentially-expressed in cell cultures with different confluences. Additionally, we measured the expression of other miRNAs, such as miR-152, miR-130a, miR-132, miR-212 and miR-200a, with known roles in beta cell function. We did not see any significant expression changes of miR-375 nor any of the two targets, in both the rat and human beta cell lines at different confluences. Interestingly, among the other miRNAs measured, the expression of miR-132 and miR-212 positively correlated with confluence, but only in the INS-1 832/13 cells. Our results show that the expression of miR-375 and other miRNAs with known roles in beta cell function is independent of, or at least minimally influenced by the density of proliferating adherent cells, especially within the confluence range optimal for functional assays to elucidate miRNA-dependent regulatory mechanisms in the beta cell.Entities:
Keywords: Cell density; Confluence; Diabetes; Pancreatic beta cell; miR-375; microRNA
Year: 2017 PMID: 28674658 PMCID: PMC5493031 DOI: 10.7717/peerj.3503
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Figure 1Experimental design and average cell-to-cell distance at harvest.
(A) Rat (INS-1832/13) and human (EndoC-βH1) insulin-secreting cell lines were seeded at different cell densities prior to downstream assays as outlined. (B) The average distance between cells at different harvest confluences for EndoC-βH1 cells. Data are presented as mean ± SEM of N = 40–90 distance measurements from three independent seedings. (∗∗∗) p < 0.001; one-way ANOVA Tukey’s multiple comparison test.
Figure 2Expression of miR-375 and its targets in INS-1 832/13 cells (A–C) or in EndoC-βH1 cells (D–F).
(A) miR-375 expression at different cell confluence of INS-1 832/13 cells. Expression was normalized to rat U87. (B and C) Aifm1 and Cav1 expression in INS-1 832/13 cells, respectively. Expression was normalized to Hprt1 and Ppia. (D) Expression of miR-375 at different cell density in EndoC-βH1 cells. Expression was normalized to human RNU44 and RNU48. (E and F) AIFM1 and CAV1 expression in EndoC-βH1 cells, respectively. Expression were normalized to HPRT1 and PPIA. For all experiments, data are presented as mean of N = 3–4 biological replicates, (∗) p < 0.05 using one-way ANOVA Tukey’s multiple comparison test.
Figure 3miR-132 and miR-212 expression in INS-1 832/13 cells (A–B) or in EndoC-βH1 cells (C–D) at different confluences.
Expression was normalized to rat U87 or to human RNU44 and RNU48. Data are presented as mean ± SEM of N = 3–4 biological replicates. (∗) p < 0.05, (∗∗) p < 0.01, (∗∗∗) p < 0.001; one-way ANOVA Tukey’s multiple comparison test.